Related Experiment Video
Updated: Oct 25, 2025

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
[A toddler with status dystonicus due to medication]
Birgit van Dooijeweert1,2, Anna Vera D Verschuur3, Nora A Visser4
1Meander Medisch Centrum, Amersfoort: Afd. Kindergeneenskunde.
Insights
Status dystonicus (SD) is a severe condition causing generalized dystonia, often triggered by medications like metoclopramide. Prompt treatment involving trigger removal and supportive care is crucial for patient recovery.
Area of Science:
- Neurology
- Pediatric Neurology
- Emergency Medicine
Background:
- Status dystonicus (SD) is a critical neurological condition characterized by severe generalized dystonia.
- It can lead to significant respiratory and metabolic complications, with a mortality rate around 10%.
- Potential triggers include infections, metabolic disturbances, and certain medications.
Background:
Status dystonicus (SD) is a severe episode of generalized dystonia, potentially complicated by respiratory and metabolic disruption. Triggers can be infection, medication, or metabolic disturbance. The prognosis is variable and mortality is approximately 10%.
Case Description:
An 18 month old girl presented to the ER with clinical suspicion of a febrile status epilepticus and was evaluated according to APLS principles. Eventually, a SD became apparent, with generalized dystonic features at examination. Most likely, the episode was provoked by a single dose of metoclopramide. Her clinical state improved rapidly, possibly aided by administration of biperiden.
Conclusion:
Treatment of SD encompasses elimination or treatment of the trigger, stabilization of vital functions, possible administration of sedatives and dystonia specific medication. Metoclopramide holds a relatively high risk for extrapyramidal complications (1-10%) and dystonia (0.1-1.5%), even within therapeutic range. The use of anti-emetics with less alarming side effect profiles, for example ondansetron, is recommended.
More Related Videos
Related Concept Videos
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Mania and Antimanic Drugs: Overview
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Depolarizing Blockers: Pharmocokinetics
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

